Related Experiment Video
Updated: May 5, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization
Li He1, Jamie Fong, Mark von Zastrow
1Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, CA 94608, USA.
Abstract:
The utility of morphine for the treatment of chronic pain is hindered by the development of tolerance to the analgesic effects of the drug. Morphine is unique among opiates in its ability to activate the mu opioid receptor (MOR) without promoting its desensitization and endocytosis. Here we demonstrate that [D-Ala(2)-MePhe(4)-Gly(5)-ol] enkephalin (DAMGO) can facilitate the ability of morphine to stimulate MOR endocytosis. As a consequence, rats treated chronically with both drugs show reduced analgesic tolerance compared to rats treated with morphine alone. These results demonstrate that endocytosis of the MOR can reduce the development of tolerance, and hence suggest an approach for the development of opiate analogs with enhanced efficacy for the treatment of chronic pain.
Insights
Morphine tolerance, a challenge in chronic pain management, can be reduced. Combining morphine with DAMGO facilitates mu opioid receptor (MOR) endocytosis, significantly decreasing analgesic tolerance in rats.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Management
Background:
- Chronic pain treatment is limited by morphine tolerance.
- Morphine activates mu opioid receptors (MOR) without promoting desensitization or endocytosis.
- Developing strategies to overcome analgesic tolerance is crucial for effective pain management.
Purpose of the Study:
- To investigate if DAMGO can facilitate MOR endocytosis induced by morphine.
- To determine if co-administration of morphine and DAMGO reduces analgesic tolerance.
- To explore the potential of MOR endocytosis as a therapeutic target for chronic pain.
Main Methods:
- Utilized [D-Ala(2)-MePhe(4)-Gly(5)-ol] enkephalin (DAMGO) to target MOR.
- Administered morphine and DAMGO to rats for chronic treatment.
- Assessed analgesic tolerance by comparing drug efficacy over time.
Main Results:
- DAMGO facilitated morphine-induced MOR endocytosis.
- Rats treated with both morphine and DAMGO exhibited reduced analgesic tolerance compared to morphine-only treatment.
- MOR endocytosis was shown to mitigate the development of analgesic tolerance.
Conclusions:
- MOR endocytosis is a viable mechanism to reduce opioid analgesic tolerance.
- Co-administration of MOR-internalizing agents with morphine offers a potential strategy for improved chronic pain therapy.
- This research paves the way for developing novel opioid analogs with sustained analgesic efficacy.
More Related Videos
Related Concept Videos
GPCR Desensitization
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids

